Steris (MEX:STE N) Research & Development: MXN2,065 Mil (TTM As of Mar. 2026)


MEX:STE N Steris PLC MEX:STE N
90 GF Score
Price MXN3,824.43
GF Value MXN4,960.30
! 1 Warning Sign
View Full Analysis

What is Steris Research & Development?

Steris MEX:STE N 90 Research & Development is MXN2,065 Mil as of Mar. 2026. GuruFocus rates MEX:STE N with a GF Score™ of 90/100 and a GF Value™ of MXN4,960.30. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Steris's Research & Development for the three months ended in Mar. 2026 was MXN519 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was MXN2,065 Mil.

Steris  (MEX:STE N) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Steris Research & Development Related Terms

Steris Research & Development Historical Data

* Premium members only.

The historical data trend for Steris's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Steris Research & Development Chart

Steris Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,725.55 1,775.05 1,721.03 2,201.30 2,035.89

Steris Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 564.65 497.09 517.31 531.17 519.34
MEX:STE N
90GF Score
Steris PLC MEX:STE N
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Steris Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN2,065 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of MXN2,065 Mil mean?
Steris (MEX:STE N) has a Research & Development of MXN2,065 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Steris and its competitors.
Is Steris' Research & Development too high?
Steris' current Research & Development is MXN2,065 Mil. Overall, Steris has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Steris' Research & Development compare to ZBH and GEHC?
Steris' Research & Development of MXN2,065 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Steris and its competitors. Steris's current Research & Development is MXN2,065 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steris stock overvalued right now?
Steris (MEX:STE N) has a current Research & Development of MXN2,065 Mil. The stock's GF Value™ is MXN4,960.30, compared to a current price of MXN3,824.43 — trading 22.9% below its estimated fair value. The current Research & Development is MXN2,065 Mil. Steris' overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Steris (MEX:STE N), the current Research & Development is MXN2,065 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Steris (MEX:STE N) Overvalued in 2026?

Based on GuruFocus' analysis, Steris stock appears to be undervalued. The current stock price of MXN3,824.43 is trading 22.9% below its estimated GF Value™ of MXN4,960.30.

Key valuation signals for MEX:STE N:

  • Research & Development: MXN2,065 Mil
  • GF Value™: MXN4,960.30 vs. price of MXN3,824.43 (22.9% below fair value)
  • GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the MEX:STE N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Steris Business Description

Address 70 Sir John Rogerson\'s Quay, Dublin, IRL, D02 R296
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
90GF Score

Get the complete analysis for MEX:STE N

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,824.43
Price
MXN4,960.30
GF Value